Mental Health Clinics in The Colony, TX Accepting Medicare
12 Mental Health Clinics found. Showing 1 - 12
 Prime Wellness Center Pllc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 4901 Windhaven Pkwy Ste 200, The Colony, TX 75056 Phone: 469-777-4688 Fax: 469-253-6167 |
New Beginnings Neuropsychology, Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 7552 Main St, Building B, The Colony, TX 75056 Phone: 469-731-5440 Fax: 469-731-5537 |
Novel Therapy, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 6600 Paige Rd Ste 215, The Colony, TX 75056 Phone: 469-269-2826 |
Luv On The Move Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 5625 Trego St, The Colony, TX 75056 Phone: 469-269-0389 |
Bryson Family Services Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 7109 Fox Dr, The Colony, TX 75056 Phone: 214-783-3806 |
Spectrum Of Grace Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 5504 Rock Canyon Rd, The Colony, TX 75056 Phone: 951-230-2160 |
Reflections Lifestyle Center Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4901 Windhaven Pkwy Ste 200, The Colony, TX 75056 Phone: 469-777-4688 Fax: 469-253-6167 |
Healing Hearts Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 7552 Main St, Suite 200, The Colony, TX 75056 Phone: 972-662-8347 |
My Coping Center Llc Counselor Medicare: Medicare Enrolled Practice Location: 5812 Hamilton Dr, The Colony, TX 75056 Phone: 217-454-6113 |
Life Improvement For Everyone Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 6805 Main St Ste 430 #313, The Colony, TX 75056 Phone: 972-467-5204 |
Caring Disability Provider And Assisted Living, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 5044 Lake Vista Dr, The Colony, TX 75056 Phone: 469-556-9933 |
Bariatric Bridge Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7274 Waters Edge Dr, The Colony, TX 75056 Phone: 855-957-3825 Fax: 844-957-3825 |
News Archive
New report on launch trend of Roche's Actemra
BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends®: ACTEMRA. Roche, Inc. announced that they received FDA approval for Actemra (generic name: tocilizumab) on January 8th. This represents the first IL-6 receptor inhibitor agent approved for Rheumatoid Arthritis (RA); Actemra is approved for adult patients with moderately-to-severely active RA who have had an inadequate response to one or more TNF antagonist therapies. Actemra represents the fourth IV Infusion product in the RA Market and the first infusion product with monthly maintenance dosing.
SAMHSA awards System of Care Expansion Planning grants up to nearly $4 million
The Substance Abuse and Mental Health Services Administration (SAMHSA) is awarding System of Care Expansion Planning grants totaling up to nearly $4 million. The purpose of these grants is to develop a comprehensive strategic plan to expand and sustain the system of care approach to providing services for children and youth with serious emotional disturbances and their families.
Tree nut consumption linked to better nutrient adequacy, diet quality in adults
A new study, published this week in the open access journal Nutrients, compares the nutrient adequacy and diet quality of those who consume tree nuts (almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts), and non-tree nut consumers in a nationally representative population.
AeroScout to provide RFID Asset Tracking And Management Solutions for Premier's ASCEND program
Following the recent announcement of an agreement between Premier Purchasing Partners, L.P., and AeroScout, the Premier healthcare alliance announced today that it has selected AeroScout as the sole source provider of RFID Asset Tracking and Management solutions for Premier's ASCEND™ program.
FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Lamivudine and Zidovudine Tablets, 30 mg/60 mg.
› Verified 3 days ago